CNTA
Centessa Pharmaceuticals Plc
NASDAQ · Healthcare · Biotechnology · GB
$40.50
+0.00%Latest reported
- Last report date
- May 5, 2026
- EPS actual
- -$0.52
- EPS estimate
- -$0.38
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -20.1%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 5, 2026 | -$0.38 | -$0.52 | Miss -36.84% | — |
| Mar 31, 2026 | -$0.37 | -$0.48 | Miss -29.73% | — |
| Nov 5, 2025 | -$0.39 | -$0.41 | Miss -5.13% | — |
| Aug 12, 2025 | -$0.35 | -$0.38 | Miss -8.57% | — |
| May 14, 2025 | -$0.35 | -$0.20 | Beat 42.86% | $15.0M |
| Mar 24, 2025 | -$0.38 | -$0.34 | Beat 10.53% | $952.3K |
| Nov 13, 2023 | -$0.46 | -$0.40 | Beat 13.04% | — |
| Aug 14, 2023 | -$0.43 | -$0.26 | Beat 39.53% | — |
| May 12, 2023 | -$0.41 | -$0.53 | Miss -29.27% | — |
| Nov 10, 2022 | -$0.49 | -$0.57 | Miss -16.33% | — |
| Aug 10, 2022 | -$0.56 | -$0.69 | Miss -23.21% | — |
| May 16, 2022 | -$0.70 | -$0.60 | Beat 14.29% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 5, 2026